The European Medicines Agency (EMA) announced, Thursday 18 March 2021, that: Vaccine The British “Oxford-AstraZeneca” was “safe and effective”, according to statements made by Emer Cook, Executive Director of the European Medicines Agency, at a press conference attended by the Chair of the Vaccine Evaluation Committee, Sabine Strauss, following a review of the safety of the vaccine, against the background of reports of blood clots occurring in some people Who have received the vaccine.
Over the past week, several European countries, including: Germany, France, Italy, Sweden, Ireland, the Netherlands, Denmark and Norway, announced the suspension of vaccination with the AstraZeneca vaccine as a “precaution.”
This came as a result of medical concerns following a death in Denmark about a week ago, as a result of a blood clot, after receiving the vaccine. AstraZeneca, in turn, defended the vaccine, but stressed, on the other hand, that patient safety is a “top priority.”
Its advantages outweigh its risks
Cook confirmed on the same occasion, “There is no link between the British Oxford-AstraZeneca vaccine against the Coronavirus and having blood clots.”
She also explained that “the advantages of the AstraZeneca vaccine outweigh the risks,” and added: “No quality problem has been detected in the vaccine.”
However, she stressed, on the other hand, the importance of “continuing to monitor all possible side effects of the AstraZeneca vaccine.”
And she added, “It cannot be completely ruled out that there is a link between the AstraZeneca vaccine and rare disorders of clotting (blood clotting).”
The European Agency’s statement coincides with the announcement by the Danish Medicines Agency, on Thursday evening, that it had recorded ten reports of blood clots in individuals who had received the AstraZeneca vaccine to prevent Covid-19, including one that resulted in death.
The agency added in a statement: “The Danish Medicines Agency is examining ten reports describing blood clots or their symptoms after receiving the vaccine.”
But the agency indicated that it is not possible to confirm a clear link between these cases and the vaccine.
Also “global health”
Wednesday, March 17th, a World Health Organization vaccine safety committee recommended that countries of the world continue vaccination and use the AstraZeneca vaccine, confirming that they see that the benefits that accrue from using the vaccine to prevent the Corona virus outweigh the risks, despite the decision of 12 European countries to stop Use the vaccine, this week; After concerns arose about possible side effects.
The World Health Organization had included a vaccine produced by AstraZeneca, in cooperation with the University of Oxford, in the list of emergency use last month, making it available on a larger scale to the developing world, due to its low price.
The World Health Organization said that the Global Vaccine Safety Advice Committee is carefully examining the latest available data on the safety of the AstraZeneca vaccine.
The organization also said in a statement, a day after its experts held a closed meeting, that “once the review is completed, the World Health Organization will publish the results immediately.”
The statement also added: “So far, the World Health Organization considers the benefits of using the AstraZeneca vaccine to outweigh the risks, and recommends the continuation of the vaccination campaigns.”